Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Current report no. 46/2024

Drafting date: 19 December 2024

Subject: Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Legal basis: Article 56 (1) (2) of the Act on Public Offering - current and periodic information

The Management of Captor Therapeutics S.A., based in Wrocław, Poland (the "Company") announces that on 19 December 2024, the Company's Management Board adopted a resolution on the issue of 33.138 series U ordinary bearer shares, within the limits of the Company's authorized capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.

The share issue is related to the implementation of a share-based incentive programme for employees and members of the Company's bodies. The Company discloses the content of the adopted resolution.

Detailed legal basis: § 5(9) of the Regulation of the Minister of Finance of 29 March 2018 on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required by the laws of a non-member state).